作者: Nancy E. Maestri , Elizabeth R. Hauser , Dennis Bartholomew , Saul W. Brusilow
DOI: 10.1016/S0022-3476(05)83044-6
关键词: Urea cycle 、 Diet therapy 、 Ornithine Carbamoyltransferase Deficiency Disease 、 Ornithine transcarbamylase deficiency 、 Pediatrics 、 Ornithine transcarbamylase 、 Urea cycle disorder 、 Medicine 、 Carbamoyl phosphate synthetase deficiency 、 Hyperammonemia 、 Internal medicine 、 Endocrinology
摘要: We present a diagnostic and therapeutic protocol designed to prevent clinical expression of inborn errors urea synthesis in the neonatal period, discuss long-term developmental outcome survivors. The families 32 infants, among 43 identified prenatally as being at risk for cycle disorder, chose have their infants treated according protocol, beginning birth. therapy was effective avoiding hyperammonemic coma death seven patients with carbamoyl phosphate synthetase deficiency, argininosuccinate lyase deficiency. When prospectively, five eight ornithine transcarbamylase deficiency avoided severe hyperammonemia survived period. Two two subsequently died; three additional latter disorder received orthotopic liver transplants. Our experience suggests that these surviving had more favorable neurologic than rescued from coma. However, all them require burdensome medical regimen may handicaps include impairment development recurrent episodes hyperammonemia. Further, those or high mortality rate.